Open AccessSynergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: Doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells
Author(s) -
Khosit Pinmai,
Sriharut Chunlaratthanabhorn,
Chatri Ngamkitidechakul,
Noppamas Soonthornchareon,
Chariya Hahnvajanawong
Publication year - 2008
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.14.1491
Subject(s) - phyllanthus emblica , cisplatin , doxorubicin , a549 cell , pharmacology , chemistry , cytotoxicity , lung cancer , liver cancer , traditional medicine , cell , hepatocellular carcinoma , cancer research , medicine , biochemistry , chemotherapy , in vitro , oncology
To examine the growth inhibitory effects of Phyllanthus emblica (P. emblica) and Terminalia bellerica (T. bellerica) extracts on human hepatocellular carcinoma (HepG2), and lung carcinoma (A549) cells and their synergistic effect with doxorubicin or cisplatin.